ANALYSIS OF MAST CELL DENSITY IN NORMAL ORAL MUCOSA VS DIFFERENT GRADES OF ORAL SQUAMOUS CELL CARCINOMA
DOI:
https://doi.org/10.61841/4mp3az90Keywords:
Mast cell, Oral Squamous Cell Carcinoma,, angiogenesis, neovascularizationAbstract
BACKGROUND-Mast cells display a diversity of roles in extracellular matrix degradation, angiogenesis and innate and purchased immune responses, thanks to their ability to release a variety of pre-formed mediators, including cytokines, vasoactive amines, and enzymes on activation. Angiogenesis or neovascularization is crucial for development and progression of malignant tumors. This biologic process is regulated by angiogenic factors, like basic fibroblast protein (bFGF), vascular endothelial protein (VEGF), tumor necrosis factor-α (TNF-α), and angiogenic inhibitors, like angiostatin, platelet coagulation factor (PF4) and thrombospondin-1 (TSP-1).2,3 These factors are released by tumoral and stromal cells.MATERIALS AND METHODS-Formalin-fixed, paraffin-embedded tissue specimens of 60 cases of OSCC were retrieved and divided into group 1-3 (20 poorly differentiated OSCC, 20 moderately differentiated OSCC, and 20 well differentiated OSCC). Twenty normal oral tissues of patients without any habits were included in the study, and they were selected as controls. Along with the H&E stained sections, another set of the same tissues were processed and stained with 1%Toluidine blue. 5 μm sections of formalin-fixed, paraffin blocks were deparaffinized with xylene and they were rehydrated with graded alcohols. RESULTS-Mean Mast Cell Density in Different Histological Grades of OSCC and Normal Mucosa were calculated. Group1 shows the mean Average Mast Cell (4.15±1.46), Group2 shows the mean Average Mast Cell (7.10±2.29), Group 3 shows the mean Average Mast Cell (9.35±1.72), Group 4 shows the mean Average Mast Cell (3.35±1.69).CONCLUSION-The effect of mast cells on prognosis could not be assessed in this study as time lapse between biopsy and treatment and further follow up was too less to quantify. However larger samples and large scale multi-institutional studies could provide a baseline data of MCD in different grades of OSCC. Along with this, recurrent cases and follow up studies over long periods of time like 1 – 10 years are required to validate the role and quantification of the MCD in high risk and low risk individuals, role in prognosis predilection, in planning and development of various adjuvant therapeutics strategies.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
